SOURCE: Stock Market Alerts

July 26, 2007 10:35 ET

Stock on the Move for Thursday: CYPW! July 26, 2007

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.

MIAMI, FL--(Marketwire - July 26, 2007) - Stock Market Alerts' performance stock list includes: Cyclone Power Technologies, Inc. (PINKSHEETS: CYPW), Pfizer Inc. (NYSE: PFE), Merck & Co., Inc. (NYSE: MRK), Bristol-Myers Squibb Company (NYSE: BMY).

Cyclone Power Technologies, Inc. (PINKSHEETS: CYPW) is a great stock to put on your radar and watch as Stock Market Alerts initiates coverage of the company. The company issued a press release Wednesday after the markets closed, announcing that it has signed an option for a second license agreement with Advent Power Systems, Inc.

According to Wednesday's press release, under the terms of the license option, Advent will have the exclusive right to pursue commercial applications for Cyclone's high-performance, heat-regenerative Green Revolution Engine™ with the U.S. Postal Department. The press release also states that currently, Advent holds the exclusive licensing rights for generator applications for the Cyclone engine with the U.S. Military.

Great news for CYPW investors, as the company also announced this week that it has completed its Patent Cooperation Treaty (PCT) filing for worldwide patent protection on 11 major components of its Green Revolution Engine™!

Advent paid Cyclone a non-refundable deposit upon the signing of the option. Upon the exercise of the option, Advent has agreed to pay an initial $1,000,000 royalty and a continuing per-unit royalty.

According to Harry Schoell, President and CEO of Cyclone, "Our Green Revolution Engine™ is ideal for Post Office vehicles, as the fuel actually shuts off when the vehicle is stopped and does not need to idle, making this engine a highly-efficient, earth-friendly technology for the 1000s of postal delivery trucks on America's streets."

Additionally, another press release was issued this morning announcing that, Inc. today announced that an audio interview is now available. The featured guest is Frankie Fruge, COO of Cyclone Power Technologies Inc. The interview can be heard here at

This is certainly another company for investors to watch closely! Cyclone holds the U.S. patent, international patent applications, and exclusive commercial rights to the Green Revolution Engine™, an environmentally-friendly and highly-efficient external combustion, heat-regenerative engine. Developed by Cyclone's President and CEO, Harry Schoell, the Green Revolution Engine™ regenerates (or recycles) its heat, which allows it to run cleaner, cooler and more efficiently than traditional internal combustion engines. It is capable of running on any liquid or gaseous fuel, including ethanol and propane, and is lubricated with water instead of motor oil. By eliminating many subsystems like oil pumps, radiators, catalytic converters and fuel injectors, Cyclone's Green Revolution Engine™ costs less to manufacture, operate and maintain; however, it is highly scalable and sufficiently powerful for applications ranging from lawn equipment and small home generators, large stand-alone generators, to cars, trucks, buses, RVs, boats and ships, as well as earth moving equipment and locomotives.

Before the news was released, the stock closed Wednesday at $1.75 a share.

Other Stocks of interest yesterday were:

Pfizer Inc. (NYSE: PFE) down 0.4% on 45.3 million shares traded. Pfizer is committed to helping people improve their health by discovering and developing medicines, as well as informing consumers and health care providers about our medicines and the medical conditions they treat. Through multiple initiatives, Pfizer aims to enhance access to treatments and educate, empower and motivate consumers to take the necessary steps to lead longer, healthier, happier lives.

Merck & Co., Inc. (NYSE: MRK) up 3.2% on 18.9 million shares traded. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs.

Bristol-Myers Squibb Company (NYSE: BMY) up 0.6% on 10.9 million shares traded. BMS -- an international pharmaceutical company headquartered in New York, N.Y. -- participates in the sale and marketing of Plavix in the United States through the Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership. In 2006, the Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership sold more than $3.5 billion of Plavix in the United States.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for Cyclone Power Technologies, Inc. (PINKSHEETS: CYPW). The compensation was four thousand dollars from third party, Emerging Market Consultants LLC, who is non-affiliated and may hold a significant position in the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information